The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 340:559-561 February 18, 1999 Number 7
NextNext

Thirty Years of Bone Marrow Transplantation for Severe Combined Immunodeficiency

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Buckley, R. H.
-PubMed Citation
It has been 30 years since the first patient with combined T-cell and B-cell immunodeficiency was successfully treated with transplantation of bone marrow from an HLA-identical sibling.1 Since then, hundreds of patients with severe combined immunodeficiency have been cured by the transplantation of hematopoietic progenitor cells from either a sibling or a parent who was HLA-haploincompatible (also called HLA-haploidentical, meaning that one of the two HLA haplotypes of the parent matches one of the child's, but the other parental HLA haplotype does not). Many of these patients are now long-term survivors. During the same period, the molecular basis for most . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.